Search

everythinglearnresearchcommunity

for

Search:↓

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

A patient had painful swollen lymph nodes after a cosmetic skin and hair treatment, suggesting doctors should warn about this risk.

Body and beard hair can be used for hair transplants in baldness treatment but keep their original color and curl.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Terbinafine can cause hair loss.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Low-level laser therapy helps increase hair growth in female pattern hair loss but not in telogen effluvium.

Topical Minoxidil effectively and safely regrows hair in cancer patients.

A man's severe head pain after hair transplant was greatly relieved by pulsed radiofrequency treatment.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Trichobiolight effectively treats hair loss with 82.5% success.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

A new model helps predict treatment success in girls with early puberty.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Microneedling may improve quality of life and reduce inflammation in frontal fibrosing alopecia.

Herbs like neem, tulsi, and tea tree oil may treat dandruff without side effects.

Students showed strong interest in using meniran leaves for hair growth pomade.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.